Sclerosis: all 3,103 studies
Page 22 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Influence of Exercise on the Mobility and Balance of Individuals With Multiple SclerosisCompletedNCT02524483Not applicable
- The Impact of Positive Mental Training in Multiple SclerosisCompletedNCT02524093Not applicable
- Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative StudyStatus unknownNCT02522962Not applicable
- Tecfidera Lymphocyte Chart ReviewCompletedNCT02519413
- Normobaric Hypoxic Training and Multiple SclerosisCompletedNCT02509897Not applicable
- WEB-Based Physiotherapy for People With Multiple SclerosisCompletedNCT02508961Not applicable
- Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02507713
- Open-label Study of Liothyronine in MSCompletedNCT02506751Phase 1
- Natural History of Multiple Sclerosis and Its MimickersCompletedNCT02504840
- Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic SclerosisCompletedNCT02503644Phase 2
- Comparison of Two Physical Activity Interventions in Individuals With Multiple SclerosisStatus unknownNCT02496416Not applicable
- Autologous Mesenchymal Stromal Cells for Multiple SclerosisCompletedNCT02495766Phase 1/2
- Dual Task Cost in the Upper Limb in Persons With Multiple SclerosisCompletedNCT02493166Not applicable
- Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)CompletedNCT02493049Phase 2
- A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MSCompletedNCT02490943Not applicable
- D-mannose for the Prevention of UTIs in Multiple SclerosisStatus unknownNCT02490046Phase 1
- Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and HerpesvirusStatus unknownNCT02489877
- Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral SclerosisCompletedNCT02487407Phase 2
- Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With BetaferonCompletedNCT02486640
- Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple SclerosisStatus unknownNCT02485223
- Baseline Cortical Haemodynamics in MSStatus unknownNCT02481882Not applicable
- MS Symptom Management StudyCompletedNCT02474940Not applicable
- Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple SclerosisWithdrawnNCT02472938Phase 4
- Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking ImpairmentCompletedNCT02471222Phase 2
- Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALSCompletedNCT02469675Not applicable
- Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise TherapyCompletedNCT02466165Not applicable
- A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALSStatus unknownNCT02463825Phase 2
- The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy SubjectsCompletedNCT02463318Not applicable
- Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple SclerosisCompletedNCT02461069Phase 4
- Effects of GE-O System on Gait Impairments in Multiple Sclerosis SubjectsStatus unknownNCT02459821Not applicable
- Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MSCompletedNCT02457091Phase 2
- A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple SclerosisCompletedNCT02442570Phase 2
- Standardized Ambulatory Neurorehabilitation Program for Patients With Multiple SclerosisCompletedNCT02440516Not applicable
- Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML RiskCompletedNCT02440126
- The Cognitive Variability in NF1 and TSC Monozygotic TwinsStatus unknownNCT02436746
- Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)WithdrawnNCT02428218Phase 3
- VR-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple SclerosisCompletedNCT02427997Not applicable
- A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple SclerosisTerminatedNCT02427776Phase 1/2
- Rouxbe Pilot for MSCompletedNCT02424825Not applicable
- Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS PatientsStatus unknownNCT02424669Not applicable
- Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple SclerosisCompletedNCT02424396Phase 2
- Oral Guanabenz for Multiple SclerosisTerminatedNCT02423083Phase 1
- A Task-oriented Circuit Training in Multiple SclerosisCompletedNCT02421744Not applicable
- Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis PatientsCompletedNCT02421731Not applicable
- Role of Neuromuscular Junction Function in Motor Fatigue in Multiple SclerosisCompletedNCT02418897
- A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMSTerminatedNCT02418325Phase 1/2
- F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral SclerosisCompletedNCT02414230
- Calorie Restriction in Multiple Sclerosis PatientsCompletedNCT02411838Not applicable
- Assistive Device Training in Multiple SclerosisCompletedNCT02408718Not applicable
- Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)Status unknownNCT02408380
- Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot StudyStatus unknownNCT02408367
- Microglial Activation Role In ALS (MARIA)WithdrawnNCT02405403Early Phase 1
- MRI Biomarkers in ALSCompletedNCT02405182
- MEsenchymal StEm Cells for Multiple SclerosisTerminatedNCT02403947Phase 1/2
- An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a RelapseCompletedNCT02398461Phase 1
- Characterizing Upper Extremity Function in Individuals With Multiple SclerosisCompletedNCT02398149
- Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)TerminatedNCT02394782
- An Online Self-Guided Meditation Course for Individuals With Multiple SclerosisCompletedNCT02391298Not applicable
- Falls Prevention and Balance Rehabilitation in Multiple SclerosisCompletedNCT02390830Not applicable
- Transcranial Doppler in Multiple SclerosisCompletedNCT02389426Not applicable
- Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral SclerosisCompletedNCT02383654Phase 1
- Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year ExtensionCompletedNCT02383550
- Real-Life Outcomes of Multiple Sclerosis Treatment With RebifCompletedNCT02377323Not applicable
- Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple SclerosisStatus unknownNCT02369926Phase 2
- Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability CharacteristicsCompletedNCT02369224
- A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, CanadaCompletedNCT02367222
- Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)CompletedNCT02365922
- Phototherapy in Persons With Multiple SclerosisStatus unknownNCT02365259Phase 1
- Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple SclerosisStatus unknownNCT02364986Phase 1
- A Telemedicine Mindfulness-based Intervention for People With Multiple Sclerosis and Their CaregiversCompletedNCT02364505Not applicable
- DTI in Children With Multiple SclerosisStatus unknownNCT02361697Not applicable
- Physical Capacity and Rehabilitation of Patients With Multiple SclerosisStatus unknownNCT02352194
- Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety TrialCompletedNCT02349009Phase 1/2
- Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for PhysiotherapistsCompletedNCT02346279
- Mindfulness-based Stress Reduction for Multiple SclerosisCompletedNCT02340754Not applicable
- Evaluating Pulmonary Arterial Hypertension in Patients With Systemic SclerosisWithdrawnNCT02339961Not applicable
- Psychometric Properties Mobility Measures MSCompletedNCT02339688Not applicable
- Psychometric Properties Upper Limb Function Measures Multiple SclerosisCompletedNCT02339675Not applicable
- Treatment Outcome in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT02339441
- Spinal Direct Current Stimulation Effects on Pain in Multiple SclerosisStatus unknownNCT02331654Not applicable
- Endothelial Microparticles in Systemic Sclerosis Pulmonary HypertensionCompletedNCT02331225
- Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple SclerosisCompletedNCT02330965
- Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple SclerosisTerminatedNCT02326935Phase 1
- Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and AngiomyolipomaCompletedNCT02325505
- Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to GilenyaStatus unknownNCT02325440Phase 4
- sCD163 in ALS PatientsCompletedNCT02325375
- Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)TerminatedNCT02323269
- Computerized Cognition Testing and Cognitive Motor Interference in MSCompletedNCT02318576Not applicable
- A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple SclerosisWithdrawnNCT02317263Phase 2
- Fall Risk Reduction in Multiple Sclerosis (FIRMS)Status unknownNCT02314585Not applicable
- A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668CompletedNCT02313285
- Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple SclerosisCompletedNCT02308670
- Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological DiseasesCompletedNCT02308579
- Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)CompletedNCT02308137Phase 2
- Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer AcetateCompletedNCT02307877
- Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839TerminatedNCT02306811Phase 2
- Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral SclerosisCompletedNCT02306590Not applicable
- Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02306109Not applicable
- Imaging of Intracerebral Inflammation in MSCompletedNCT02305264Not applicable
- Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic SclerosisStatus unknownNCT02302352Phase 3